PINK1-mediated mitophagy confers cancer cells with the ability to survive chemotherapy, whereas inhibiting mitophagy restores chemosensitivity in chemotherapy-treated ESCC cells (Yamashita et al., 2017). The gene discussed is PINK1; the disease is cancer.